---
title: "WVE.US (WVE.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/WVE.US/news.md"
symbol: "WVE.US"
name: "WVE.US"
parent: "https://longbridge.com/en/quote/WVE.US.md"
datetime: "2026-05-19T19:37:09.047Z"
locales:
  - [en](https://longbridge.com/en/quote/WVE.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WVE.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WVE.US/news.md)
---

# WVE.US (WVE.US) — Related News

### [Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 | WVE Stock News](https://longbridge.com/en/news/286925108.md)
*2026-05-19T05:50:29.000Z*
> Wave Life Sciences Supports AlphaDetect to Accelerate Detection of Alpha-1 | WVE Stock News

### [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
*2026-05-18T20:53:00.000Z*
> Wave Life Sciences announced positive results from the RestorAATion-2 trial, showing that WVE-006 effectively restores M

### [Wave Life Sciences Announces Positive Update on RestorAATion-2 Trial: WVE-006 (GalNAc-RNA Editing) Achieves MZ-Like Phenotype Across Both Biweekly and Monthly Dosing | WVE Stock News](https://longbridge.com/en/news/286817368.md)
*2026-05-18T12:30:00.000Z*
> Wave Life Sciences announced positive results from the RestorAATion-2 trial for WVE-006, showing its potential to treat 

### [Wave Life Sciences ATS Data Could Support RNA Editing Platform, Wedbush Says](https://longbridge.com/en/news/286602718.md)
*2026-05-15T18:40:00.000Z*
> Wedbush Securities anticipates that Wave Life Sciences will present data from its RestorAATion-2 study at the ATS 2026 c

### [Wave Life Sciences Signals Momentum In Earnings Call](https://longbridge.com/en/news/284672405.md)
*2026-04-30T00:50:57.000Z*
> Wave Life Sciences held its Q1 earnings call, reporting a 315% revenue increase to $38.2 million, driven by licensing an

### [WAVE Life Sciences (NASDAQ:WVE)  Shares Down 7.6%   - Here's What Happened](https://longbridge.com/en/news/284618799.md)
*2026-04-29T17:34:49.000Z*
> WAVE Life Sciences (NASDAQ:WVE) shares fell 7.6% to $6.9460, with trading volume down 79% from average levels. Analysts